Full Length Research Paper
References
|
Abou Gabal AA, Essawy AE, Abdel-Moneim AM, Hame SS, Elzergy AA (2007). The protective effect of black seed (Nigella sativa) against carbon tetrachloride-induced chromosomal aberrations and ultrastructural changes of bone marrow cells. Arab J. Biotechnol. 10(2):275-288. |
|
|
Aboul-Ela EI (2002). Cytogenetic studies on Nigella sativa seeds extract and thymoquinone on mouse cells infected with schistosomiasis using karyotyping. Mutat. Res. 516(1-2):11-7. |
|
|
Al-Jassabi S, Azirun MS (2010). Phenytoin-Induced Hepatic 8-Hydroxy-deoxyguanosine in DNA of Balb/C Mice and Its Reduction by Curcumin. Mohd . Am-Eurasian J. Toxicol. Sci. 2(3):129-133. |
|
|
Anderson ME (1985). Tissue glutathione. In: Greenwald, R., A., ed. Handbook of methods for oxygen radical research. Boca Raton: CRC Press. pp. 317-323. |
|
|
Anzenbacher P, Anzenbacherová E (2001). Cytochromes P450 and metabolism of xenobiotics. Cell Mol. Life Sci. 58(5-6):737-47. |
|
|
Badary OA, Abd-Ellah MF, El-Mahdy MA, Salama SA, Hamada FM (2007). Anticlastogenic activity of thymoquinone against benzo(a)pyrene in mice. Food Chem. Toxicol. 45(1):88-92. |
|
|
Badary OA, Taha RA, Gamal el-Din AM, Abdel-Wahab MH (2003). Thymoquinone Is a Potent Superoxide Anion Scavenger. Drug Chem. Toxicol. 26:87-98. |
|
|
Bajpayee M, Pandey AK, Parmar D, Dhawan A (2005). Current Status of Short-Term Tests for Evaluation of Genotoxicity, Mutagenicity, and Carcinogenicity of Environmental Chemicals and NCEs. Toxicol. Mech. Methods 15(3):155-80. |
|
|
Basta-Kaim A, Budziszewska B, Lasoń W (2008). Effects of antiepileptic drugs on immune system. Przegl Lek. 65(11):799-802. |
|
|
Beulter E, Duron O, Kelly BM (1963). Improved method for the determination of blood glutathione. J. Lab. Clin. Med. 61:882-8. |
|
|
Calderón-Ezquerro C, Sánchez-Reyes A, Sansores RH, Villalobos-Pietrini R, Amador-Mu-oz O, Guerrero-Guerra C, Calderón-Segura ME, Uribe-Hernández R, Gómez-Arroyo S (2007). Cell proliferation kinetics and genotoxicity in lymphocytes of smokers living in Mexico City. Hum. Exp. Toxicol. 26(9):715-22. |
|
|
Carrano AV, Natarajan AT (1988). International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC publication no. 14. Considerations for population monitoring using cytogenetic techniques. Mutat. Res. 204(3):379-406. |
|
|
Corona-Rivera A, Urbina-Cano P, Bobadilla-Morales L, Vargas-Lares Jde J, Ramirez-Herrera MA, Mendoza-Magaua ML, Troyo-Sanroman R, Diaz-Esquivel P, Corona-Rivera JR (2007). Protective in vivo effect of curcumin on copper genotoxicity evaluated by comet and micronucleus assays. J. Appl. Genet. 48(4):389-96. |
|
|
Daba MH, Abdel-Rahman MS (1998). Hepatoprotective activity of thymoquinone in isolated rat hepatocytes. Toxicol. Lett. 95:23-29. |
|
|
Dailey LA, Imming P (1999). 12-Lipoxygenase: classification, possible therap-eutic benefits from inhibition and inhibitors. Curr. Med. Chem. 6(5):389-98. |
|
|
Draper W, Hadley M (1990). Indirect determination of oxygen free radicals. Methods Enzymol. 186:421-431. |
|
|
Durante M, Furusawa Y, Gotoh E (1998). A simple method for simultaneous interphase-metaphase chromosome analysis in biodosimetry. Int. J. Radiat. Biol. 74(4):457-62. |
|
|
El Hamss R, Idaomar M, Alonso-Moraga A, Mu-oz Serrano A (2003). Antimutagenic properties of bell and black peppers. Food Chem. Toxicol. 41(1):41-7. |
|
|
El-Sheikh AA, Morsy MA, Hamouda AH (2016). Protective Mechanisms of Thymoquinone on Methotrexate-induced Intestinal Toxicity in Rats. Pharmacogn. Mag. 12(Suppl 1):S76-81. |
|
|
EroÄŸlu HE (2011). The cytogenetic effects of black tea and green tea on cultured human lymphocytes. Braz. Arch. Biol. Technol. 54(6)1159-1165. |
|
|
Galloway SM, Armstrong MJ, Reuben C, Colman S, Brown B, Cannon C, Bloom AD, Nakamura F, Ahmed M, Duk S, Rimpo J, Margolin BH, Resnick MA, Anderson B, Zeiger E (1987). Chromosome aberrations and sister chromatid exchanges in Chinese hamster ovary cells: Evaluation of 108 chemicals. Environ. Mol. Mutagen. 10(10):1-175. |
|
|
Gökce EC, Kahveci R, Gökce A, Cemil B, Aksoy N, Sargon MF5, Kısa Ü, ErdoÄŸan B, Güvenç Y, Alagöz F, Kahveci O (2016). Neuroprotective effects of thymoquinone against spinal cord ischemia-reperfusion injury by attenuation of inflammation, oxidative stress, and apoptosis. J. Neurosurg. Spine 24(6):949-59. |
|
|
Ibrahim ZS, Alkafafy ME, Ahmed MM, Soliman MM (2016). Renoprotective effect of curcumin against the combined oxidative |
|
|
International Agency for Research on Cancer (IARC) (1996). Some Pharmaceutical Drugs; Phenytoin. IARC Monogr. Eval. Carcinog. Risks Hum. 66:175-237. |
|
|
Iqbal M, Okazaki Y, Okada S (2009). Curcumin attenuates oxidative damage in animals treated with a renal carcinogen, ferric nitrilotriacetate (Fe-NTA): implications for cancer prevention. Mol. Cell. Biochem. 324(1-2):157-64. |
|
|
Jacobsen NW, Halling-Sorensen B, Birkved FK (2008). Inhibition of human aromatase complex (CYP19) by antiepileptic drugs. Toxicol. In Vitro. 22(1):146-53 |
|
|
Kannan TP, Quah BB, Azlina A, Samsudin AR (2006). Mitotic Index and Chromosomal Analyses for Hydroxyapatite Implantation in Rabbits. Arch. Orofacial Sci. 1:15-20. |
|
|
Kaul A, Kalla NR, Goyle S (2001). The modulatory effect in genotoxic responses due to age and duration of PHT-therapy inepileptic patients. Teratog. Carcinog. Mutagen. 21(2):135-49. |
|
|
Khader M, Bresgen N, Eckl PM (2009). In vitro toxicological properties of thymoquinone. Food Chem. Toxicol. 47(1):129-33. |
|
|
Kim PM, Winn LM, Parman T, Wells PG (1997). UDP-glucuronosyl-transferasemediated protection against in vitro DNA oxidation and micronucleus formation initiated by phenytoin and its embryotoxic metabolite 5-(p-hydroxyphenyl)-5- phenylhydandoin. J. Pharmacol. Exp. Ther. 280:200-209. |
|
|
Kindig D, Garriott ML, Parton JW, Brunny JD, Beyers JE (1992). Diphenylhydantoin is not genotoxic in a battery of short-term cytogenetic assays. Teratog. Carcinog. Mutagen. 12(1):43-50. |
|
|
Kubow S, Wells PG (1989). In vitro bioactivation of phenytoin to a reactive free radical intermediate by prostaglandin synthetase, horseradish peroxidase, and thyroid peroxidase. Mol. Pharmacol. 35(4):504-11. |
|
|
Leonard A, de Meester C, Fabry L, de Saint- Georges L, Dumont P (1984). Lack o f muta- genicity of diphenylhydantoin in in vitro short-term tests. Mutat. Res. 137:79-88. |
|
|
Maclouf J, Grassi J, Pradelles P (1987). Development of enzyme-immunoassay techniques for the measurement of eicosanoids: In Walden TL Jr, Hughes HN (eds.), Prostaglandin and Lipid Metabolism in Radiation Injury, Plenum Press, Rockville. pp. 355-364. |
|
|
Malhotra A, Nair P, Dhawan DK (2012). Curcumin and resveratrol in combination modulates benzo(a)pyrene-induced genotoxicity during lung carcinogenesis. Hum Exp Toxicol. 31(12):1199-206. |
|
|
Mays DC, Pawluk LJ, Apseloff G, Davis WB, She ZW, Sagone AL, Gerber N (1995). Metabolism of phenytoin and covalent binding of reactive intermediates in activated humanneutrophils. Biochem. Pharmacol. 50(3):367-80. |
|
|
National Toxicology Program (NTP) (1993). Toxicology and Carcinogenesis Studies of 5,5-Diphenylhydantoin (CAS No. 57-41-0) (Phenytoin) in F344/N Rats and B6C3F1 Mice (Feed Studies). Natl. Toxicol. Program Technol. Rep. Ser. 404:1-303. |
|
|
Parman T, Chen G, Wells PG (1998). Free radical intermediates of phenytoin and related teratogens. Prostaglandin H synthase-catalyzed bioactivation, electron paramagnetic resonance spectrometry, and photochernical product analysis. J. Biol. Chem. 273(39):25079-88. |
|
|
Poddar S, Talukder G, Sharma A (2004). Chromosome Damage Induced by Ferric Chloride in Human Peripheral Lymphocytes. Int. J. Hum. Genet. 4(4):261-264. |
|
|
Ponnala S, Rao KP, Chaudhury JR, Ahmed J, Rama Rao B, Kanjilal S, Hasan Q, Das UN (2009). Effect of polyunsaturated fatty acids on diphenyl hydantoin-induced genetic damage in vitro and in vivo. Prostaglandins Leukot Essent Fatty Acids. 80(1):43-50. |
|
|
Poojan S, Kumar S, Verma V, Dhasmana A, Lohani M, Verma MK (2015). Disruption of Skin Stem Cell Homeostasis following Transplacental Arsenicosis; Alleviation by Combined Intake of Selenium and Curcumin. PLoS One 10(12):e0142818. |
|
|
Pradelles P, Grassi J, Maclouf J (1985). Enzyme immunoassays of eicosanoids using acetylcholinesterase as label: An alternative to radioimmunoassay. Anal. Anal. Chem. 57(7):1170-3. |
|
|
Sankar P, Telang AG, Ramya K, Vijayakaran K, Kesavan M, Sarkar SN (2014). Protective action of curcumin and nano-curcumin against arsenic-induced genotoxicity in rats in vivo. Mol. Biol. Rep. 41(11):7413-22. |
|
|
Sbrana I, Zaccaro L, Lascialfari D, Ceccherini I, Loprieno N (1984). Human lymphocytes assay: cyclophosphamide metabolic activation by S9 system with low cytotoxicity. Mutat. Res. 130(6):411-6. |
|
|
Schaumann BA, Winge VB, Pederson M, Kuskowski MA (1990). Comparative effects of phenytoin and/or phenobarbital treatment on sister chromatid exchange. Epilepsia 31:453-457. |
|
|
Sezzano P, Raimondi A, Arboix M, Pantarotto C (1982). Mutagenicity of diphenyl- hydantoin and some of its metabolites towards Salmonella typhinzurium strains. Mutat. Res. 3:219-228. |
|
|
Siddique YH, Ara G, Beg T, Gupta J, Afzal M (2010). Assessment of cell viability, lipid peroxidation and quantification of DNA fragmentation after the treatment of anticancerous drug mitomycin C and curcumin in cultured human blood lymphocytes. Exp. Toxicol. Pathol. 62(5):503-8. |
|
|
Snyder RD (2009). An Update on the Genotoxicity and Carcinogenicity of Marketed Pharmaceuticals with Reference to In Silico Predictivity. Environtl. Mol. Mutagen. 50:435-450. |
|
|
Snyder RD, Greenb JW (2001). A review of the genotoxicity of marketed pharmaceuticals. Mutat. Res. 488:151-169. |
|
|
Soga Y, Nishimura F, Ohtsuka Y, Araki H, Iwamoto Y, Naruishi H, Shiomi N, Kobayashi Y, Takashiba S, Shimizu K, Gomita Y, Oka E (2004). CYP2C polymorphisms, phenytoin metabolism and gingival overgrowth in epileptic subjects. Life Sci. 74(7):827-34. |
|
|
Stacey NH, Klaassen CD (1981). Copper toxicity in isolated rat hepatocytes. Toxicol. Appl. Pharmacol. 58:211-220. |
|
|
Tawfik SS, Abouelella AM, Shahein YE (2013). Curcumin protection activities against γ-rays-induced molecular and biochemical lesions. BMC Res. Notes 6:375. |
|
|
Tay SP, Cheong SK, Hamidah NH, Ainoon O (1998). Flow cytometric analysis of intracellular myeloperoxidase distinguishes lymphocytes, monocytes and granulocytes. Malays. J. Pathol. 20(2):91-4. |
|
|
Ugur S, Ulu R, Dogukan A, Gurel A, Yigit IP, Gozel N, Aygen B, Ilhan N (2015). The renoprotective effect of curcumin in cisplatin-induced nephrotoxicity. Ren. Fail. 37(2):332-6. |
|
|
Watson RR (1992). In in Vitro Methods of Toxicology. CRC Press. CRC Press, Boca Raton, Ann Arbor, London, Tokyo. pp. 204-216. |
|
|
Winn LM, Kim PM, Nickoloff JA (2003). Oxidative stress-induced homologous recombination as a novel mechanism for phenytoin-initiated toxicity. J. Pharmacol. Exp. Ther. 306(2):523-7. |
|
|
Witczak M, Ferenc T, Lopaczyńska D, Nowakowska D, Kociszewska I, Wilczyński J (2008). The effect of antiepileptic drugs administered in pregnancy on micronucleus frequency in cordblood lymphocytes. Int. J. Occup. Med. Environ. Health 21(1):67-71. |
|
|
Woodruff RC, Mason JM, Valencia R, Zimmering S (1985). Chemical mutagenesis testing in Drosophila. V. Results o f 53 coded compounds tested for the National Toxicology Program. Environ. Mutagen. 7(5):677-702. |
|
|
Zegura B, Lah TT, Filipic M (2004). The role of reactive oxygen species in microcystin-LR-induced DNA damage. Toxicology 200(1):59-68. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
